Medtronic plc (FRA:2M6)
Market Cap | 105.86B |
Revenue (ttm) | 29.14B |
Net Income (ttm) | 3.97B |
Shares Out | n/a |
EPS (ttm) | 3.08 |
PE Ratio | 26.66 |
Forward PE | 16.72 |
Dividend | 2.54 (3.08%) |
Ex-Dividend Date | Sep 26, 2025 |
Volume | 1,200 |
Average Volume | 855 |
Open | 82.59 |
Previous Close | 82.52 |
Day's Range | 82.15 - 82.66 |
52-Week Range | 68.50 - 90.89 |
Beta | n/a |
RSI | 56.03 |
Earnings Date | Nov 18, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Validea Detailed Fundamental Analysis - MDT
Below is Validea's guru fundamental report for MEDTRONIC PLC (MDT). Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...

EQS-News: Techsomed and Medtronic to Collaborate on Image Guided Ablation Therapy
EQS-News: Techsomed / Key word(s): Agreement Techsomed and Medtronic to Collaborate on Image Guided Ablation Therapy 16.10.2025 / 15:10 CET/CEST The issuer is solely responsible for the content of thi...
Truist Securities Raises Medtronic (MDT) Price Target to $103 | MDT Stock News
Truist Securities Raises Medtronic (MDT) Price Target to $103 | MDT Stock News
Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Medtronic Stock's $50 Billion Gift To Investors
In the last decade, Medtronic (MDT) stock has returned a notable $52 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let's look at some numbers and compare how this pa...
Medtronic plc (MDT) Special Call - Slideshow
Medtronic Plc (MDT) Altaviva Device Management Call Transcript
Medtronic plc - Special Call
Medtronic plc - Special CallCompany ParticipantsRyan Weispfenning - VP & Head of Investor RelationsEmily ElswickConference Call ParticipantsRyan...
Stifel Raises Medtronic (MDT) Price Target to $105, Maintains Hold Rating | MDT Stock News
Stifel Raises Medtronic (MDT) Price Target to $105, Maintains Hold Rating | MDT Stock News
November 28th Options Now Available For Medtronic (MDT)
Investors in Medtronic PLC (Symbol: MDT) saw new options begin trading today, for the November 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDT options ...

Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
TIME Best Inventions honors extraordinary innovations changing lives DUBLIN , Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Bra...

Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit
Presentation to provide comprehensive overview of AVIM Therapy clinical evidence demonstrating the potential to halt the progression of hypertensive heart disease Orchestra BioMed and Medtronic (NYSE:...

Medtronic Delivers on FY25 Sustainability Targets and Charts Path to 2030
A landmark year for the company's impact journey, Medtronic not only achieved but also exceeded its Scope 1 and 2 emissions intensity target in FY25 NORTHAMPTON, MA / ACCESS Newswire / October 8, 2025...

Medtronic Kicks Off US Study On Robot-Assisted Surgeries For Women
Medtronic announces U.S. clinical ... Full story available on Benzinga.com
Medtronic (MDT) Launches Clinical Study for Robotic Surgery System
Medtronic (MDT) Launches Clinical Study for Robotic Surgery System

Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures
First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY...
Medtronic (MDT) Receives Buy Rating and Increased Price Target from Citigroup | MDT Stock News
Medtronic (MDT) Receives Buy Rating and Increased Price Target from Citigroup | MDT Stock News

Medtronic Joins U.N. Call to Action Against High Blood Pressure
United Nations recommends “utmost urgency” in dealing with the disease NORTHAMPTON, MA / ACCESS Newswire / September 30, 2025 / The United Nations (U.N.) called on member nations to commit "with the u...
Medtronic (MDT) Announces Successful â¬1.5 Billion Notes Offering
Medtronic (MDT) Announces Successful â¬1.5 Billion Notes Offering

Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
GALWAY, Ireland , Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public of...
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
GALWAY , Ireland , Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public ...
Medtronic (MDT) Suffers a Larger Drop Than the General Market: Key Insights
In the closing of the recent trading day, Medtronic (MDT) stood at $94.3, denoting a -1.5% move from the preceding trading day.

Medtronic: FY26 Outlook Strengthened By New Product Launches
Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating. MDT's innovation pipeline, portfolio transformation, and spin-off of the d...